Pharmaceuticals Brazil

Brazil Psoriasis Treatment Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Brazil Psoriasis Treatment Market Industry Trends and Forecast to 2034: Segmented by (Drug Class, Severity, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $928.0 Mn Placeholder estimate
Estimate 2025 $1.01 Bn 2.9% of the global market
Projected 2034 $2.08 Bn 106.7% Adds $1.07 Bn over 9 forecast years
CAGR 2025–2034 8.4% Faster than 42% of 180 Pharmaceuticals markets here
Key players 6 +1
  • Brazil is 2.93% of the global market.
  • In Latin America, the largest is Brazil (this report) at $1.01 Bn.
  • Fastest growing: Brazil (this report) at 8.4% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$1.07 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Psoriasis Treatment Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $928.0 Mn — —
2025 (base) $1.01 Bn +$78.0 Mn —
2026 (forecast) $1.09 Bn +$84.5 Mn +8.4%
2027 (forecast) $1.18 Bn +$91.6 Mn +17.5%
2028 (forecast) $1.28 Bn +$99.3 Mn +27.4%
2029 (forecast) $1.39 Bn +$107.6 Mn +38.1%
2030 (forecast) $1.51 Bn +$116.7 Mn +49.7%
2031 (forecast) $1.63 Bn +$126.5 Mn +62.2%
2032 (forecast) $1.77 Bn +$137.1 Mn +75.9%
2033 (forecast) $1.92 Bn +$148.6 Mn +90.6%
2034 (forecast) $2.08 Bn +$161.1 Mn +106.7%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $34.35 Bn
  2. North America $18.91 Bn
  3. US $15.56 Bn
  4. Europe $6.89 Bn
  5. APAC $6.41 Bn
  6. Canada $2.67 Bn
  7. China $2.41 Bn
  8. Japan $2.34 Bn
  9. Latin America $1.60 Bn
  10. Middle East $1.36 Bn
  11. Germany $1.21 Bn
  12. Brazil (this report) $1.01 Bn
  13. France $828.2 Mn
  14. Italy $804.8 Mn
  15. UK $775.8 Mn
  16. Ecuador $787.1 Mn
  17. Spain $559.4 Mn
  18. Mexico $561.5 Mn
  19. Saudi Arabia $565.9 Mn
  20. India $569.2 Mn
  21. Africa $528.4 Mn
  22. Australia $400.9 Mn
  23. New Zealand $382.8 Mn
  24. Russia $304.9 Mn
  25. South Africa $249.9 Mn
  26. UAE $175.8 Mn
  27. Egypt $94.0 Mn
  28. Philippines $69.7 Mn
  29. Malaysia $61.8 Mn
  30. Hong Kong $54.0 Mn
  31. Thailand $44.5 Mn
  32. Singapore $39.4 Mn
  33. Kenya $23.1 Mn

Report snapshot

Brazil Psoriasis Treatment Market Analysis at a glance
Market size, 2025$1.01 Bn placeholder estimate
Forecast, 2034$2.08 Bn placeholder estimate
Growth (CAGR), 2025–20348.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsDrug class, severity and end user (see all)
Key playersJohnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and 1 more (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
Active clinical trials15 in BrazilSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil Psoriasis Treatment Market Analysis Executive Summary

Psoriasis treatments clear red, scaly skin patches using creams, light therapy, pills and biologic injections.

Key segments of the psoriasis Treatment market include drug class (IL-17 Inhibitors, IL-23 Inhibitors and TNF Inhibitors) and severity (Mild and Moderate to Severe).

Bar chart: Brazil Psoriasis Treatment market size, 2024–2034, placeholder estimates. $928.0 Mn in 2024, $1.01 Bn in 2025 and $2.08 Bn in 2034, 8.4% CAGR.
Brazil Psoriasis Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil Psoriasis Treatment Market Dynamics

Market Growth Drivers

Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.

Opportunity

Treatments for men, at-home options, digital consultations and growth in Asia and the Middle East give the psoriasis Treatment market room to grow.

Market Restraints

Treatments are mostly paid out of pocket, results and safety vary between providers, and economic slowdowns can reduce spending on the psoriasis Treatment market.

Competitive Landscape for Psoriasis Treatment Market in Brazil

The psoriasis Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Psoriasis Treatment Market in Brazil

Psoriasis Treatment in Brazil: rules, payment and research

Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2] ClinicalTrials.gov lists 15 studies on Psoriasis Treatment that are recruiting, active or about to start in Brazil.⁠[3]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for psoriasis Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Psoriasis Treatment right now, from free public sources.

Clinical trials

15 active trials in Brazil

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Johnson & Johnson 16 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Bristol-Myers Squibb 16 active trials on ClinicalTrials.gov (opens in a new tab)
  3. AbbVie Inc. 12 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Novartis AG 7 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Takeda Pharmaceutical Company Ltd 7 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Latest research 926 papers since 2021 (worldwide)

  1. Evaluation of Anti-psoriatic Treatment Awareness, Prescription Patterns, and Adverse Effects in Patients with Psoriasis - A Questionnaire-Based Study. Indian journal of dermatology, 2026
  2. Network pharmacology-based investigation of the therapeutic effects and molecular mechanisms of oxymatrine in psoriasis. Frontiers in pharmacology, 2026
  3. Localized Hydrogen Release Driven by Mg-Pd Microgalvanic Cells from 3D-Printed Microneedles Reverses Redox Homeostasis for Psoriasis Treatment. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026
  4. IL23-axis cytokines and C-reactive protein as dissociable biomarkers of vascular recovery in psoriasis: A hypothesis. Immunologic research, 2026
  5. Dual-layer silk fibroin microneedles with differential solubility for sequential methotrexate release: A topical treatment strategy for psoriasis. Biomaterials advances, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Psoriasis Treatment in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Psoriasis Treatment market in Brazil?
Placeholder estimate: about $1.01 Bn in 2025, rising to about $2.08 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Psoriasis Treatment market in Brazil growing?
Placeholder estimate: about 8.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Psoriasis Treatment market report cover?
The report splits the market by drug class (IL-17 Inhibitors, IL-23 Inhibitors, TNF Inhibitors, Oral Drugs and more), severity (Mild, Moderate to Severe) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Psoriasis Treatment market?
Key players include Johnson & Johnson, AbbVie Inc., Novartis AG, Eli Lilly and Company, UCB and Amgen Inc..
What is driving the Psoriasis Treatment market?
Rising interest in appearance, social media, more affordable treatments and new minimally invasive options are driving the psoriasis Treatment market. More clinics and chains are opening in fast-growing cities.
Who regulates Psoriasis Treatment in Brazil?
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How many clinical trials on Psoriasis Treatment are running in Brazil?
15 studies are recruiting, active or about to start in Brazil, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
How much research is published on Psoriasis Treatment?
PubMed lists 926 papers on Psoriasis Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Psoriasis Treatment in Brazil? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Collagen Supplements: Skin, Joints and Real EvidenceCollagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions… Patient Support Programmes: Helping Patients Stay on TreatmentWHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Brazil

See all
Same topic, other categories

Related on autoimmune diseases and skin and hair

See the topic